Dexcom G6 CGM system has received the CE Mark for use during pregnancy in the EU, and will be available soon, starting with the UK in spring 2020.
Poorly controlled glucose levels in pregnant women with Type 1, Type 2 or gestational diabetes can lead to serious problems for the mother and child, and the solutions for managing diabetes during pregnancy are currently limited. The CE Mark of the Dexcom G6 for pregnant women provides more choice for both healthcare professionals and patients to manage their disease.
Helen Murphy, MD, professor of medicine at the University of East Anglia in Norwich, U.K. “CGM eliminates the need for fingersticks and provides patients with regular updates and alerts throughout the day and night. This allows them to manage their glucose levels with confidence during pregnancy and helps them to deliver healthy babies.”